All In MedTech

FDA Clearance Tracker · P130008-S073

Inspire II Upper Airway Stimulator

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Sep 10, 2021 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Sep 10, 2021

Approved

Time to decision

28 days

Received Aug 13, 2021. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P130008-S073
Device name
Inspire II Upper Airway Stimulator
Applicant location
Maple Grove, MN
Received
Aug 13, 2021
Decided
Sep 10, 2021
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P130008

Device type

Device class
Class III

Every decision under product code MNQ

FDA's approval statement

As written in FDA's record.

Approval for the revised protocol for the post-approval study (PAS) protocol.

Source documents

Other decisions for Inspire Medical Systems

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.